Chromatin Accessibility and Regulatory Network Modulation by Endocrine Disrupters

Information

  • Research Project
  • 9266194
  • ApplicationId
    9266194
  • Core Project Number
    R01ES023185
  • Full Project Number
    7R01ES023185-04
  • Serial Number
    023185
  • FOA Number
    PA-14-078
  • Sub Project Id
  • Project Start Date
    6/1/2016 - 8 years ago
  • Project End Date
    5/31/2017 - 7 years ago
  • Program Officer Name
    TYSON, FREDERICK L.
  • Budget Start Date
    6/1/2016 - 8 years ago
  • Budget End Date
    5/31/2017 - 7 years ago
  • Fiscal Year
    2016
  • Support Year
    04
  • Suffix
  • Award Notice Date
    6/15/2016 - 8 years ago

Chromatin Accessibility and Regulatory Network Modulation by Endocrine Disrupters

DESCRIPTION (provided by applicant): Our current understanding of how endocrine-disrupting chemicals (EDCs), such as the hormone mimics ('xenoestrogens') modify and maintain chromatin states, gene expression patterns and alter genomic nuclear receptor binding and chromatin structural patterns is nascent. Chromatin accessibility plays a major role in shaping the binding landscape of nuclear hormone receptors and all transcription factors. DNaseI hypersensitivity mapping provides a powerful approach for global, generic, and precise delineation of regulatory DNA. In this proposal, we aim to apply these powerful approaches to map alterations in the regulatory DNA landscape associated with EDCs, and to define the impact of EDC exposure on transcriptional control networks. Focusing on xenoestrogens, we aim to characterize systematically the impact of exposure on the regulatory DNA landscape using model cell lines as well as specialized primary cell and primary human tissue culture systems. We will also address major outstanding questions concerning transient exposures to EDCs giving rise to lasting phenotypic effects, and analyze transcriptional regulatory networks perturbed by EDCs.

IC Name
NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
  • Activity
    R01
  • Administering IC
    ES
  • Application Type
    7
  • Direct Cost Amount
    346144
  • Indirect Cost Amount
    31856
  • Total Cost
    378000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    113
  • Ed Inst. Type
  • Funding ICs
    NIEHS:378000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZES1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES
  • Organization Department
  • Organization DUNS
    079715609
  • Organization City
    SEATTLE
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    981213622
  • Organization District
    UNITED STATES